Market Dr Reddy’s shares jump 9% after co settles patent litigation for Revlimid with Celgene Updated : September 18, 2020 12:52 PM IST The share price gained as much as 9.86 percent to hit a 52-week high of Rs 5,302.85 apiece on the BSE. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.